secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omada Health, Inc. (OMDA)
CIK:        0001611115
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-032063
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omada Health Q1 revenue $78M (+42% YoY); members top 1M, net loss narrows to $3M
--------------------------------------------------------------------------------

- Revenue $78M, up 42% YoY; total members 1.02M, up 51% YoY.
- Net loss $3M vs $9M in Q1 2025; adjusted EBITDA positive $1M vs -$4M.
- Joined Optum Rx Weight Engage; now relationships with all three top PBMs covering 80% of U.S. prescription claims.
- Gross margin 62% (non-GAAP 64%), up from 58% (non-GAAP 60%) YoY.
- Announced independent program administrator for Eli Lilly Employer Connect; GLP-1 Care Track data shows 1.8x weight loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026032063/0001628280-26-032063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026032063/omda-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-032063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer